Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase - Xue,Q.; Nagy,J.A.; Manseau,E.J.; Phung,T.L.; Dvorak,H.F.; Benjamin,L.E. (Arterioscler Thromb Vasc Biol, 2009)